Loading...
Loading...
India's dapagliflozin imports from GERMANY total $59.4K across 59 shipments from 15 foreign suppliers. PRIVAPOSERVICES GMBH leads with $23.3K in import value; the top 5 suppliers together control 75.7% of this origin. Leading Indian buyers include ALEMBIC PHARMACEUTICALS LIMITED. This corridor reflects India's pharmaceutical import demand for dapagliflozin — a diversified sourcing base with multiple active suppliers from GERMANY.

PRIVAPOSERVICES GMBH is the leading Dapagliflozin supplier from GERMANY to India, with import value of $23.3K across 27 shipments. The top 5 suppliers — PRIVAPOSERVICES GMBH, NewLife Biopharma Limited, ILAPO, SAVI CLINICALS FZ LLC, privaposervices GmbH — collectively account for 75.7% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | PRIVAPOSERVICES GMBH | $23.3K | 27 | 39.1% |
| 2 | NewLife Biopharma Limited | $8.1K | 3 | 13.7% |
| 3 | ILAPO | $5.9K | 4 | 9.9% |
| 4 | SAVI CLINICALS FZ LLC | $4.3K | 2 | 7.3% |
| 5 | privaposervices GmbH | $3.4K | 2 | 5.7% |
| 6 | RX SOLUTION LIMITED | $2.2K | 2 | 3.8% |
| 7 | ILAPO-INTERNATIONALE LUDWIGS- | $2.0K | 4 | 3.3% |
| 8 | NEW LIFE MEDICALS (USA) INC | $1.8K | 2 | 3.0% |
| 9 | ESPEE PHARMA (UK ) LTD | $1.7K | 1 | 2.8% |
| 10 | ADIRAMEDICA LIMITED | $1.4K | 2 | 2.3% |
| 11 | SRIGEN PHARMA LTD. | $1.3K | 1 | 2.1% |
| 12 | NEWLIFE BIOPHARMA LIMITED | $1.1K | 1 | 1.9% |
| 13 | RX SOLUTION LTD | $1.1K | 2 | 1.8% |
| 14 | SRIGEN PHARMA LTD., | $702 | 2 | 1.2% |
| 15 | E-PHARM LIMITED | $693 | 2 | 1.2% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ALEMBIC PHARMACEUTICALS LIMITED | $8.1K | 3 | 13.7% |
| 2 | MACLEODS PHARMACEUTICALS LTD | $6.0K | 4 | 10.1% |
| 3 | HETERO LABS LIMITED | $5.9K | 4 | 9.9% |
| 4 | MANKIND PHARMA LIMITED | $4.3K | 2 | 7.3% |
| 5 | DR.REDDY'S LABORATORIES LTD | $4.1K | 5 | 6.9% |
| 6 | ZYDUS LIFESCIENCES LIMITED | $4.0K | 4 | 6.7% |
| 7 | INVENTIA HEALTHCARE LIMITED | $3.4K | 2 | 5.7% |
| 8 | CIPLA LIMITED | $2.8K | 3 | 4.7% |
| 9 | UMEDICA LABORATORIES PRIVATE LIMITED | $2.5K | 2 | 4.2% |
| 10 | WATSON PHARMA PRIVATE LIMITED | $2.0K | 4 | 3.3% |
| 11 | TITAN LABORATORIES PRIVATE LIMITED | $1.9K | 1 | 3.2% |
| 12 | CLIANTHA RESEARCH LIMITED | $1.9K | 2 | 3.2% |
| 13 | CENTAUR PHARMACEUTICALS PRIVATE LIMITED | $1.8K | 2 | 3.0% |
| 14 | M. J. BIOPHARM PRIVATE LIMITED | $1.7K | 1 | 2.8% |
| 15 | UNISON PHARMACEUTICALS PRIVATE LIMITED | $1.5K | 2 | 2.6% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Dapagliflozin suppliers from GERMANY to India include PRIVAPOSERVICES GMBH, NewLife Biopharma Limited, ILAPO. The leading supplier is PRIVAPOSERVICES GMBH with import value of $23.3K USD across 27 shipments. India imported Dapagliflozin worth $59.4K USD from GERMANY in total across 59 shipments.
India imported Dapagliflozin worth $59.4K USD from GERMANY across 59 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Dapagliflozin sourced from GERMANY include ALEMBIC PHARMACEUTICALS LIMITED, MACLEODS PHARMACEUTICALS LTD, HETERO LABS LIMITED. The largest buyer is ALEMBIC PHARMACEUTICALS LIMITED with $8.1K in imports across 3 shipments.
The total value of Dapagliflozin imports from GERMANY to India is $59.4K USD, across 59 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
59 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists